优化PET/CT与SPECT/CT在感染成像中的应用:采集、解读与陷阱
本综述系统阐述F18-FDG PET/CT与放射性标记白细胞SPECT/CT在复杂感染性疾病中的应用路线图,涵盖患者选择、采集、功能数据与CT形态学联合解读策略,并探讨药物干扰、技术伪影及生物模拟等诊断陷阱,强调结构化报告对多学科团队沟通和诊断准确性的价值。
要点
- 混合成像(F18-FDG PET/CT与放射性标记白细胞SPECT/CT)已革新复杂感染性疾病的诊断与管理。
- 感染成像正从主观视觉评估转向多参数、定量、标准化的方法。
- 需警惕药物干扰、技术伪影和生物模拟等诊断陷阱,结构化报告有助于多学科沟通。
核心结论
- 感染成像领域正经历从主观视觉评估向多参数、定量和标准化方法的转变,结构化报告是向多学科团队传达可操作循证数据的关键工具。
研究设计与样本
- 本综述提供从患者选择到整合解读策略的分子成像全面路线图,涵盖功能数据与CT形态学特征的协同利用。
主要发现
- 综述探讨了涵盖药物干扰、技术伪影和生物模拟在内的多种诊断陷阱。
临床怎么用
- 临床应采用多参数、定量和标准化的感染成像方法,并利用功能数据与CT形态学特征的协同进行整合解读。
- 应识别并规避药物干扰、技术伪影和生物模拟等诊断陷阱,并通过结构化报告向多学科团队传达可操作的循证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The adoption of hybrid imaging, including F18-FDG PET/CT and radiolabeled leukocyte (WBC) SPECT/CT, has revolutionized the diagnosis and management of complex infectious diseases. Following the successful precedent of harmonization in oncology, the field of infection imaging is undergoing a similar transformation from subjective visual assessment to a multiparametric, quantitative, and standardized approach. This review provides a comprehensive roadmap for molecular imaging-from patient selection to integrated interpretation strategies that leverage the synergy between functional data and morphological CT hallmarks and explores various diagnostic pitfalls encompassing pharmacological interference, technical artifacts, and biological mimickers. Finally, structured reporting is highlighted as a vital tool for communicating actionable, evidence-based data to the multidisciplinary team, ultimately improving diagnostic accuracy and patient outcomes in the era of personalized medicine.
引用
- Arnon-Sheleg E, Keidar Z. Optimizing PET/CT and SPECT/CT in infection imaging: Acquisition, interpretation, and pitfalls. Semin Nucl Med. 2026. PMID: 42020287. doi:10.1053/j.semnuclmed.2026.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。